FDA approves drug to treat hot flashes resulting from menopause
The daily pill is the first of its kind approved to treat hot flashes.
Watch CBS News
The daily pill is the first of its kind approved to treat hot flashes.
The agency said that blood donor eligibility will now be based on an individual's personal risks.
The product could be the first nasal spray for severe allergic reactions.
Federal health advisers recommended that a popular birth control pill be sold over the counter. The move paves the way for customers to be able to buy the contraceptive without a prescription for the first time in the U.S. Meg Oliver reports.
Perrigo wants to sell its Opill brand birth control pills in stores without a prescription.
Drugmaker HRA Pharma wants to sell birth control pills without a prescription.
Discount retail chain pulled bottles of the pain medication off shelves at an unspecified number of its stores.
"Trends indicate that demand for Wegovy in the U.S. will exceed our current supply capacity," the company said in an announcement.
Up to 10,000 deaths and 160,000 hospitalizations a year are caused by RSV in seniors.
Wisconsin's conservative-controlled Supreme Court ruled a hospital couldn't be forced to give a deworming drug to a patient with COVID-19, saying a county judge did not cite a legal basis for ordering the facility to administer ivermectin.
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.
North Dakota's Republican Gov. Doug Burgum has signed a bill that restricts transgender health care and criminalizes providers who provide gender-affirming care to people under 18.
The Centers for Disease Control and Prevention is expected to sign off on guidance for another COVID-19 vaccine booster for higher-risk groups. Meanwhile, a new subvariant of the virus first detected in India is spreading across the U.S. Dr. Matifadza Hlatshwayo Davis, director of health for the city of St. Louis, joins CBS News to discuss.
A few days after a federal judge in Texas moved to suspend the abortion drug mifepristone, the Supreme Court intervened to temporarily preserve FDA approval and consumer access to it. Nancy Cordes reports.
Limits on how late into a pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to take effect Saturday at 1 a.m.
Milk aisles have more options than ever, from the cow dairy you grew up drinking to a plethora of alternative options like oat, almond, soy and more. Here's how their nutrition compares.
Attorney General Merrick Garland said in a statement the Justice Department "strongly disagrees" with the decision from an appeals court.
Florida is the latest example of how quickly and dramatically state laws are changing in the wake of last year's Supreme Court decision striking down Roe v. Wade.
The court maintained access to mifepristone for the time being but is only letting it be dispensed after a doctor's office visit, not by mail, and up to seven weeks into a pregnancy, not 10.
Some chemicals in U.S. food are banned in other countries, but California could be the first state to get rid of these additives. Danya Bacchus reports.
The rulings from federal judges in Texas and Washington were issues less than 20 minutes apart, the Justice Department said.
A California state assembly member has proposed a ban on red dye No. 3 and four other food additives in the state based on potential links to cancer and other health concerns. The additives are allowed by the FDA and food manufacturers say they're safe, but they have been banned in Europe for years. CBS News' Danya Bacchus reports.
Two federal judges issued conflicting rulings Friday over the FDA's longstanding approval of the abortion pill mifepristone. A Texas judge halted the FDA's approval, while in a separate case, a Washington state judge blocked the FDA from making changes to mifepristone's availability. Skyler Henry has the latest.
The FDA on Wednesday approved Narcan, a nasal spray that helps reverse opioid overdoses, for over-the-counter sales without a prescription. New York City Health Commissioner Dr. Ashwin Vasan joins CBS News to discuss how this could help curb opioid deaths.
In the 12-month period ending in Oct. 2022, the United States recorded 101,750 overdose deaths, primarily from opioids.